Skip to main content

Investors Grab MTNB 9.7% Lower Than Its Secondary Stock Offering

Looking back to 3 days ago, Matinas BioPharma Holdings Inc (MTNB) priced a 32,260,000 share secondary stock offering at $1.55 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time..
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.